Articles
Healthcare Venture Award Presentation: Update (10/31/23) Fukuda’s company TrichoSeeds was selected as a finalist at the 5th Healthcare Venture Award event which took place in Tokyo, Japan on October 27, 2023. The event featured innovative biotechnology companies from Japan, especially those which focused on extending healthspan and longevity. Follicle Thought was fortunate to capture an…
Read More
Hi Everyone, this is a check-in to keep you abreast of what’s going on with the website and to announce a few hair-growth news items. Yokohama and Fries, Please First, I’m pleased to announce I have an exclusive update regarding the “french fry hair growth” craze which was clobbering headlines around the world for the…
Read More
One of the most interesting companies working on a cellular hair growth therapy, HairClone of the UK, has just released their first newsletter update of 2018. The contents of the newsletter have been divided into business updates and scientific updates for the company. One of the updates mentions a crowdfunding campaign video from HairClone and…
Read More
Stem cells and ‘the cure for hair loss.’ In our minds they go hand-in-hand, don’t they? Since the initial emergence of stem cell technologies in regenerative medicine, many have wondered if these technologies could be used to treat hair loss or alopecia. Today, many stem cell companies are developing technologies that would appear to make…
Read More
A lot has changed in the hair growth industry since I began Follicle Thought three years ago. Many new names and glimmers of hope have shown up in the industry. Even celebrity hair restoration has become more widespread and talked about. These are all positive developments which support the ultimate goal we are heading towards.…
Read More
Last week I had the opportunity to join a video conference with the HCell team to discuss their therapy aimed at multiple forms of alopecia. The HCell company emerged on the internet around mid January 2018 through the announcement of their Orphan Drug Designation from the FDA to treat pediatric alopecia areata. That press release…
Read More
An interesting bit of news was released by the company Follicum this morning. In conjunction with a specialized research company Dualsystems Biotech, Follicum has identified receptors in hair follicle cells that their lead drug candidate FOL-005 binds to. This represents a viable mechanism of action for their product. The press release mentions this information could…
Read MoreA Happy New Year to all of you from Follicle Thought. I’ve always enjoyed doing the year ahead preview posts and this one is no exception. A new year does bring us new opportunities and should be a reason for renewed hope. This is also the first year since I’ve started Follicle Thought that a…
Read More
(Updated 1/5/18 with Teslabrush Photos) The electrifying startup, HairCell, has just launched its new website. HairCell is part of the Leonhardt Ventures portfolio, a venture creation lab that focuses on regenerative medtech and regenerative economy startups. The core technology of HairCell is a bioelectric stimulator device that controls expressions of specific proteins in sequence for regenerative…
Read More
Rophe Pharma submitted a press release this week announcing its topical hair growth drug has shown positive results for restoring eyebrows. Rophe’s hair growth candidate RPHE-7193 is a topical form of the FDA approved blood pressure drug hydralazine. The drug apparently has a similar mechanism to minoxidil. Here’s a quote from the press release which…
Read More